{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T04:34:15Z","timestamp":1769315655422,"version":"3.49.0"},"reference-count":56,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"36","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Society of Clinical Oncology Educational Book"],"published-print":{"date-parts":[[2016,5]]},"abstract":"<jats:p>Outcomes for patients with lung cancer have been improved substantially through the integration of surgery, radiation, and systemic therapy for patients with early-stage disease. Meanwhile, advances in our understanding of molecular mechanisms have substantially advanced our treatment of patients with advanced lung cancer through the introduction of targeted therapies, immune approaches, improvements in chemotherapy, and better supportive care. However, the majority of these advances have occurred among patients with good functional status, normal organ function, and with the social and economic support systems to be able to benefit most from these treatments. The aim of this article is to bring greater attention to management of lung cancer in patients who are medically compromised, which remains a major barrier to care delivery. Impaired performance status is associated with poor outcomes and correlates with the high prevalence of cachexia among patients with advanced lung cancer. CT imaging is emerging as a research tool to quantify muscle loss in patients with cancer, and new therapeutics are on the horizon that may provide important adjunctive therapy in the future. The benefits of cancer therapy for patients with organ failure are poorly understood because of their exclusion from clinical trials. The availability of targeted therapy and immunotherapy may provide alternatives that may be easier to deliver in this population, but clinical trials of these new agents in this population are vital. Patients with lower socioeconomic status are disproportionately affected by lung cancer because of higher rates of tobacco addiction and the impact of socioeconomic status on delay in diagnosis, treatment, and outcomes. For all patients who are medically compromised with lung cancer, multidisciplinary approaches are particularly needed to evaluate these patients and to incorporate rapidly changing therapeutics to improve outcomes.<\/jats:p>","DOI":"10.1200\/edbk_158713","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T17:46:40Z","timestamp":1540835200000},"page":"e484-e491","source":"Crossref","is-referenced-by-count":3,"title":["Treatment of Lung Cancer in Medically Compromised Patients"],"prefix":"10.1200","author":[{"given":"Jeffrey","family":"Crawford","sequence":"first","affiliation":[{"name":"Department of Medicine and Solid Tumor Therapeutics Program, Duke Cancer Institute, Duke University Medical Center, Durham, NC; Division of Medical Oncology, University of Ottawa, The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada; University of Maryland Greenebaum Cancer Center, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Wheatley-Price","sequence":"additional","affiliation":[{"name":"Department of Medicine and Solid Tumor Therapeutics Program, Duke Cancer Institute, Duke University Medical Center, Durham, NC; Division of Medical Oncology, University of Ottawa, The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada; University of Maryland Greenebaum Cancer Center, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine Louella","family":"Feliciano","sequence":"additional","affiliation":[{"name":"Department of Medicine and Solid Tumor Therapeutics Program, Duke Cancer Institute, Duke University Medical Center, Durham, NC; Division of Medical Oncology, University of Ottawa, The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada; University of Maryland Greenebaum Cancer Center, Baltimore, MD."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"bibr1-EDBK_158713","first-page":"191","volume-title":"Evaluation of Chemotherapeutic Agents","author":"Karnofsky DA","year":"1949"},{"key":"bibr2-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.1894"},{"key":"bibr3-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70218-7"},{"key":"bibr4-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70153-0"},{"key":"bibr5-EDBK_158713","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/MCO.0b013e3283455d45","volume":"14","author":"Prado CM","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"bibr6-EDBK_158713","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nrd4467","volume":"14","author":"Cohen S","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"bibr7-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70055-X"},{"key":"bibr9-EDBK_158713","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1470-2045(14)71154-4","volume":"16","author":"Garcia JM","year":"2015","journal-title":"Lancet Oncol"},{"key":"bibr11-EDBK_158713","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/jcsm.12083","volume":"6","author":"Fearon K","year":"2015","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"bibr12-EDBK_158713","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.lfs.2014.11.029","volume":"125","author":"Alves CR","year":"2015","journal-title":"Life Sci"},{"key":"bibr14-EDBK_158713","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2015.33.15_suppl.e17681","volume":"33","author":"Brule S","year":"2015","journal-title":"J Clin Oncol"},{"key":"bibr15-EDBK_158713","unstructured":"Al-Baimani K, Jonker H, Zhang T, et al. Are clinical trial eligibility criteria an accurate reflection of a real world population of advanced lung cancer patients. Presented at: World Conference on Lung Cancer; 2015 Denver, CO; Abstract 1398."},{"key":"bibr16-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011954"},{"key":"bibr17-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.08.163"},{"key":"bibr18-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061884"},{"key":"bibr19-EDBK_158713","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(09)61497-5","volume":"374","author":"Ciuleanu T","year":"2009","journal-title":"Lancet Oncol"},{"key":"bibr20-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810699"},{"key":"bibr21-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214886"},{"key":"bibr22-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504627"},{"key":"bibr23-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.3708"},{"key":"bibr25-EDBK_158713","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/hrt.2006.098814","volume":"93","author":"Friedrich EB","year":"2007","journal-title":"Heart"},{"key":"bibr26-EDBK_158713","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/hep.21563","volume":"45","author":"Kamath PS","year":"2007","journal-title":"Hepatology"},{"key":"bibr27-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1000678"},{"key":"bibr28-EDBK_158713","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/annonc\/mdp598","volume":"21","author":"Janus N","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"bibr29-EDBK_158713","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/07357900600629567","volume":"24","author":"Brandes JC","year":"2006","journal-title":"Cancer Invest"},{"key":"bibr31-EDBK_158713","volume-title":"The Health Consequences of Smoking: A Report of the Surgeon General","author":"U.S. Department of Health and Human Services","year":"2004"},{"key":"bibr33-EDBK_158713","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/jnci\/91.7.614","volume":"91","author":"Wiencke JK","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"bibr34-EDBK_158713","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/jech.57.10.802","volume":"57","author":"Gilman SE","year":"2003","journal-title":"J Epidemiol Community Health"},{"key":"bibr35-EDBK_158713","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/00001648-199309000-00010","volume":"4","author":"Hegmann KT","year":"1993","journal-title":"Epidemiology"},{"key":"bibr36-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2012.301002"},{"key":"bibr37-EDBK_158713","first-page":"29","volume":"63","author":"Agaku IT","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"bibr38-EDBK_158713","first-page":"54","volume":"100","author":"Burns ME","year":"2001","journal-title":"WMJ"},{"key":"bibr39-EDBK_158713","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1158\/1055-9965.EPI-07-2726","volume":"17","author":"Fu SS","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"bibr40-EDBK_158713","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2307\/3342593","volume":"16","author":"Hackbarth DP","year":"1995","journal-title":"J Public Health Policy"},{"key":"bibr41-EDBK_158713","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1353\/hpu.2007.0120","volume":"18","author":"Yerger VB","year":"2007","journal-title":"J Health Care Poor Underserved"},{"key":"bibr42-EDBK_158713","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/jnci\/87.20.1538","volume":"87","author":"Evans N","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"bibr43-EDBK_158713","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/add.12718","volume":"110","author":"Cantrell J","year":"2015","journal-title":"Addiction"},{"key":"bibr44-EDBK_158713","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.2105\/AJPH.2013.301300","volume":"103","author":"Vijayaraghavan M","year":"2013","journal-title":"Am J Public Health"},{"key":"bibr45-EDBK_158713","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/jamainternmed.2014.6674","volume":"175","author":"Haas JS","year":"2015","journal-title":"JAMA Intern Med"},{"key":"bibr46-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70032-9"},{"key":"bibr47-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026321923883"},{"key":"bibr48-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2009-038ST"},{"key":"bibr49-EDBK_158713","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/cncr.24986","volume":"116","author":"Yang R","year":"2010","journal-title":"Cancer"},{"key":"bibr50-EDBK_158713","author":"Pateman K","journal-title":"Addiction"},{"key":"bibr51-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102873"},{"key":"bibr53-EDBK_158713","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00408-014-9671-9","volume":"193","author":"Lam VK","year":"2015","journal-title":"Lung"},{"key":"bibr54-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2015.06.005"},{"key":"bibr55-EDBK_158713","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jamcollsurg.2015.03.056","volume":"221","author":"Melvan JN","year":"2015","journal-title":"J Am Coll Surg"},{"key":"bibr58-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000058"},{"key":"bibr59-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26185"},{"key":"bibr60-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.9271"},{"key":"bibr61-EDBK_158713","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.47.8412"},{"key":"bibr63-EDBK_158713","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10935-013-0336-x","volume":"35","author":"Lipperman-Kreda S","year":"2014","journal-title":"J Prim Prev"},{"key":"bibr64-EDBK_158713","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/1524839913484470","volume":"15","author":"Lee YO","year":"2014","journal-title":"Health Promot Pract"},{"key":"bibr65-EDBK_158713","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/10810730.2015.1039677","volume":"21","author":"Parks MJ","year":"2016","journal-title":"J Health Commun"},{"key":"bibr66-EDBK_158713","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/ntr\/ntu345","volume":"17","author":"Christiansen BA","year":"2015","journal-title":"Nicotine Tob Res"}],"container-title":["American Society of Clinical Oncology Educational Book"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/EDBK_158713","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T21:35:01Z","timestamp":1720733701000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/EDBK_158713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":56,"aliases":["10.14694\/edbk_158713"],"journal-issue":{"issue":"36","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["10.1200\/EDBK_158713"],"URL":"https:\/\/doi.org\/10.1200\/edbk_158713","relation":{},"ISSN":["1548-8748","1548-8756"],"issn-type":[{"value":"1548-8748","type":"print"},{"value":"1548-8756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}